AstraZeneca's Stock Surge Faces Crucial Test Amid Ongoing China Probe

AstraZeneca's recent stock rally took center stage as investors await crucial insights regarding the company's ongoing probe in China. The pharmaceutical giant has found itself in a heightened spotlight after concerns arose about its business practices in the country, potentially affecting its performance and stock valuation significantly.

Continue reading